These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 24478478)

  • 21. Potential of real-time PCR threshold cycle (C
    Kamboj M; Brite J; McMillen T; Robilotti E; Herrera A; Sepkowitz K; Babady NE
    J Infect; 2018 Apr; 76(4):369-375. PubMed ID: 29229281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Point-Counterpoint: What Is the Optimal Approach for Detection of Clostridium difficile Infection?
    Fang FC; Polage CR; Wilcox MH
    J Clin Microbiol; 2017 Mar; 55(3):670-680. PubMed ID: 28077697
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of Diagnostic Algorithms for Detecting Toxigenic Clostridium difficile in Routine Practice at a Tertiary Referral Hospital in Korea.
    Moon HW; Kim HN; Hur M; Shim HS; Kim H; Yun YM
    PLoS One; 2016; 11(8):e0161139. PubMed ID: 27532104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clostridium difficile outbreak caused by NAP1/BI/027 strain and non-027 strains in a Mexican hospital.
    Morfin-Otero R; Garza-Gonzalez E; Aguirre-Diaz SA; Escobedo-Sanchez R; Esparza-Ahumada S; Perez-Gomez HR; Petersen-Morfin S; Gonzalez-Diaz E; Martinez-Melendez A; Rodriguez-Noriega E;
    Braz J Infect Dis; 2016; 20(1):8-13. PubMed ID: 26620948
    [TBL] [Abstract][Full Text] [Related]  

  • 25. How to: diagnose infection caused by Clostridium difficile.
    Gateau C; Couturier J; Coia J; Barbut F
    Clin Microbiol Infect; 2018 May; 24(5):463-468. PubMed ID: 29269092
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Economic evaluation of laboratory testing strategies for hospital-associated Clostridium difficile infection.
    Schroeder LF; Robilotti E; Peterson LR; Banaei N; Dowdy DW
    J Clin Microbiol; 2014 Feb; 52(2):489-96. PubMed ID: 24478478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A cost of illness comparison for toxigenic Clostridioides difficile diagnosis algorithms in developing countries.
    Cançado GGL; Abreu ES; Nardelli MJ; Serwa P; Brachmann M
    Anaerobe; 2021 Aug; 70():102390. PubMed ID: 34058377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Current knowledge on the laboratory diagnosis of
    Martínez-Meléndez A; Camacho-Ortiz A; Morfin-Otero R; Maldonado-Garza HJ; Villarreal-Treviño L; Garza-González E
    World J Gastroenterol; 2017 Mar; 23(9):1552-1567. PubMed ID: 28321156
    [No Abstract]   [Full Text] [Related]  

  • 29. Clostridium difficile infection diagnosis in a paediatric population: comparison of methodologies.
    Hart J; Putsathit P; Knight DR; Sammels L; Riley TV; Keil A
    Eur J Clin Microbiol Infect Dis; 2014 Sep; 33(9):1555-64. PubMed ID: 24781004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Real-time polymerase chain reaction correlates well with clinical diagnosis of Clostridium difficile infection.
    Berry N; Sewell B; Jafri S; Puli C; Vagia S; Lewis AM; Davies D; Rees E; Ch'ng CL
    J Hosp Infect; 2014 Jun; 87(2):109-14. PubMed ID: 24795170
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunochromatographic test and ELISA for the detection of glutamate dehydrogenase (GDH) and A/B toxins as an alternative for the diagnosis of Clostridioides (Clostridium) difficile-associated diarrhea in foals and neonatal piglets.
    Ramos CP; Lopes EO; Oliveira Júnior CA; Diniz AN; Lobato FCF; Silva ROS
    Braz J Microbiol; 2020 Sep; 51(3):1459-1462. PubMed ID: 32363568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Differences in outcome according to Clostridium difficile testing method: a prospective multicentre diagnostic validation study of C difficile infection.
    Planche TD; Davies KA; Coen PG; Finney JM; Monahan IM; Morris KA; O'Connor L; Oakley SJ; Pope CF; Wren MW; Shetty NP; Crook DW; Wilcox MH
    Lancet Infect Dis; 2013 Nov; 13(11):936-45. PubMed ID: 24007915
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Health care-associated infections: a meta-analysis of costs and financial impact on the US health care system.
    Zimlichman E; Henderson D; Tamir O; Franz C; Song P; Yamin CK; Keohane C; Denham CR; Bates DW
    JAMA Intern Med; 2013 Dec 9-23; 173(22):2039-46. PubMed ID: 23999949
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Asymptomatic carriage of toxigenic Clostridium difficile by hospitalized patients.
    Guerrero DM; Becker JC; Eckstein EC; Kundrapu S; Deshpande A; Sethi AK; Donskey CJ
    J Hosp Infect; 2013 Oct; 85(2):155-8. PubMed ID: 23954113
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of multilocus variable number of tandem repeats analysis genotyping to determine the role of asymptomatic carriers in Clostridium difficile transmission.
    Curry SR; Muto CA; Schlackman JL; Pasculle AW; Shutt KA; Marsh JW; Harrison LH
    Clin Infect Dis; 2013 Oct; 57(8):1094-102. PubMed ID: 23881150
    [TBL] [Abstract][Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.